ATE384448T1 - Symbiotische zusammensetzung - Google Patents

Symbiotische zusammensetzung

Info

Publication number
ATE384448T1
ATE384448T1 AT04726152T AT04726152T ATE384448T1 AT E384448 T1 ATE384448 T1 AT E384448T1 AT 04726152 T AT04726152 T AT 04726152T AT 04726152 T AT04726152 T AT 04726152T AT E384448 T1 ATE384448 T1 AT E384448T1
Authority
AT
Austria
Prior art keywords
symbiotic composition
composition
symbiotic
oligosaccaride
digestible
Prior art date
Application number
AT04726152T
Other languages
English (en)
Inventor
Michael Beer
Glenn R Gibson
Christopher Smejka
Original Assignee
Nestec Sa
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa, Univ Reading filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE384448T1 publication Critical patent/ATE384448T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04726152T 2003-04-08 2004-04-07 Symbiotische zusammensetzung ATE384448T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0308104.9A GB0308104D0 (en) 2003-04-08 2003-04-08 Organic compounds

Publications (1)

Publication Number Publication Date
ATE384448T1 true ATE384448T1 (de) 2008-02-15

Family

ID=9956413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726152T ATE384448T1 (de) 2003-04-08 2004-04-07 Symbiotische zusammensetzung

Country Status (15)

Country Link
US (1) US20060165670A1 (de)
EP (1) EP1613180B1 (de)
JP (1) JP2006522766A (de)
CN (1) CN1784151A (de)
AT (1) ATE384448T1 (de)
AU (1) AU2004228936B2 (de)
BR (1) BRPI0409362A (de)
CA (1) CA2521380A1 (de)
DE (1) DE602004011497D1 (de)
GB (1) GB0308104D0 (de)
MX (1) MXPA05010862A (de)
NZ (1) NZ542717A (de)
RU (1) RU2005134174A (de)
WO (1) WO2004089115A1 (de)
ZA (1) ZA200507743B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1656839A1 (de) * 2004-11-11 2006-05-17 N.V. Nutricia Nahrung, die eine Lipidmischung enthält
EP1858340B1 (de) * 2005-02-15 2010-07-14 Barry R. Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
EP1714660A1 (de) 2005-04-21 2006-10-25 N.V. Nutricia Uronsäure und Probiotika
EP2270131A1 (de) 2005-05-31 2011-01-05 The Iams Company Probiotische Katzen-Laktobazillen
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
ATE451845T1 (de) 2005-10-05 2010-01-15 Nestec Sa Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
WO2007050656A2 (en) * 2005-10-24 2007-05-03 Nestec S.A. Dietary fiber formulation and method of administration
GB0524668D0 (en) * 2005-12-02 2006-01-11 Novartis Ag Organic compounds
SI2076271T1 (sl) * 2006-10-02 2011-12-30 Friesland Brands Bv Inhibicija toksinov kolere z galatooligosaharidi (GOS)
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Ｄｆａｉｉｉの製造方法及びｄｆａｉｉｉ高含有植物エキス
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
EP2025248A1 (de) * 2007-07-31 2009-02-18 Fresenius Kabi Deutschland GmbH Zubehör zur Verhinderung von Abmagerungen
US20090061008A1 (en) * 2007-08-30 2009-03-05 Levy Mark M Fiber/granule complex for treatment of the gi tract
US10251899B2 (en) 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
CN101903398A (zh) * 2007-12-20 2010-12-01 荷兰联合利华有限公司 具有免疫刺激作用的可食用产品
JP5992654B2 (ja) * 2007-12-21 2016-09-14 ニュートリー株式会社 整腸及び／又は便通改善のための組成物
FI121912B (fi) * 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
PT2265135T (pt) * 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2760999A1 (en) * 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
CN102595936A (zh) * 2009-09-25 2012-07-18 雀巢产品技术援助有限公司 包含茶氨酸和外源性核苷酸的营养组合物
JP6006117B2 (ja) * 2009-11-12 2016-10-12 ネステク ソシエテ アノニム 腸内微生物叢バランス及び健康を促進するための栄養組成物
SG181975A1 (en) * 2009-12-29 2012-08-30 Nestec Sa Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
RU2457849C2 (ru) * 2010-01-28 2012-08-10 Геннадий Владимирович Комоско Многофункциональный синбиотический препарат, состоящий из пробиотика на основе лактобактерий, адаптогена на основе гидролизата крови и наносорбента
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
FI20105824A0 (fi) * 2010-07-26 2010-07-26 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö IV
US9125935B1 (en) * 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
US10751362B2 (en) 2016-07-18 2020-08-25 Metagenics, Inc. Compositions and methods for managing digestive disorders and a healthy microbiome
CN112806577B (zh) * 2019-11-15 2021-11-26 内蒙古伊利实业集团股份有限公司 产丁酸的益生元益生菌增效组合
CN111248443A (zh) * 2020-03-10 2020-06-09 安徽大学 一种具有改善溃疡性结肠炎的合生元组合物及其制剂与应用
CN113678895A (zh) * 2021-08-18 2021-11-23 南昌大学 一种冷藏期具有高抗氧化活性的合生元发酵乳及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
RU2190015C1 (ru) * 2001-04-27 2002-09-27 Закрытое акционерное общество "Партнер" Штамм lactobacillus brevis ba-13, используемый для приготовления пробиотических препаратов и продуктов питания
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition

Also Published As

Publication number Publication date
DE602004011497D1 (de) 2008-03-13
WO2004089115A1 (en) 2004-10-21
GB0308104D0 (en) 2003-05-14
MXPA05010862A (es) 2006-03-30
EP1613180B1 (de) 2008-01-23
ZA200507743B (en) 2007-10-31
RU2005134174A (ru) 2006-07-27
CN1784151A (zh) 2006-06-07
JP2006522766A (ja) 2006-10-05
NZ542717A (en) 2006-11-30
AU2004228936A1 (en) 2004-10-21
BRPI0409362A (pt) 2006-04-25
CA2521380A1 (en) 2004-10-21
US20060165670A1 (en) 2006-07-27
EP1613180A1 (de) 2006-01-11
AU2004228936B2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
ATE384448T1 (de) Symbiotische zusammensetzung
TW200500012A (en) Novel lactobacillus and use thereof
TW200500081A (en) Novel rotaviruses and use thereof
ITVI20030027A1 (it) Pressacavo.
ITLC20040002A1 (it) P.p.0
FI5533U1 (fi) Pitkänippipuristin
BR0200065B1 (pt) rebite elástico.
RU2003115716A (ru) Штамм lactobacillus plantarum - продуцент кормового белка
TH201000780A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000584A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001377A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001323A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001298A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001212A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001042A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000982A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000963A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000900A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000833A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000820A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000812A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000798A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201001565A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000736A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000702A (th) สิทธิบัตรยังไม่ประกาศโฆษณา

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties